NCT00384631View on ClinicalTrials.gov

Intravitreal Bevacizumab for Neovascular Glaucoma

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

March 31, 2007

Conditions
NeovascularGlaucoma
Interventions
OTHER

subconjunctival normal saline

0.1cc normal saline injection in the subconjunctival space repeated twice at monthly intervals

DRUG

Avastin

intravitreal injection of avastin 2.5mg repeated twice at monthly intervals

Trial Locations (1)

16666

Labbafinejad Medical Center, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT00384631 - Intravitreal Bevacizumab for Neovascular Glaucoma | Biotech Hunter | Biotech Hunter